%0 Journal Article
%T Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes
%A Alaaeldin Bashier
%A Amina Adil Al Qaysi
%A Azza Abdulaziz Khalifa
%A Budoor Alemadi
%A Elamin Ibrahim Abdelgadir
%A Fatheya Alawadi
%A Fawzi Bachet
%A Maryam Ahmad Al Saeed
%A Mohammed Hassanein
%A Murad Burhan Ali Bayati
%J Archive of "Oman Medical Journal".
%D 2018
%R 10.5001/omj.2018.21
%X Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) are a new class of antidiabetic drugs that might increase the risk of dehydration and hypoglycemia, particularly during the month of Ramadan in which Muslims abstain from eating and drinking for 14¨C16 hours daily. We aimed to provide real-life evidence about the safety of SGLT2-I during Ramadan
%K SGLT2
%K Fasting
%K Safety
%K Diabetes Mellitus
%K Type 2
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889836/